A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice Guidelines for Children With Croup - Full Text View

Sponsored by:	Canadian Institutes of Health Research (CIHR)
Information provided by:	University of Calgary
ClinicalTrials.gov Identifier:	NCT00147849

Purpose

The purpose of this study is to identify, from a societal perspective, the costs and associated benefits of three strategies for disseminating and implementing a practice guideline that addresses the management of croup.

Condition	Intervention
Croup	Behavioral: mailing of printed educational materials Behavioral: a combination of interactive educational meetings, educational outreach visits, and reminders Behavioral: identification of local opinion leaders and establishment of local consensus processes

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Educational/Counseling/Training, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice

Further study details as provided by University of Calgary:

Primary Outcome Measures:

Rate of hospital days per 1,000 disease episodes

Secondary Outcome Measures:

Proportion of patients treated in the ED and hospital with a corticosteroid.
Proportion of patients evaluated in ED for at least three hours after treatment with corticosteroids before the decision to admit to hospital is made.
Time to treatment with corticosteroids in both ED and hospital patients.
An economic analysis conducted from a societal perspective with costs classified as either payer (costs born by the province) or non-payer (costs born by individuals or the families of children with croup).

Study Start Date:	September 2000
Estimated Study Completion Date:	March 2006

Show Detailed Description

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Alberta hospitals were rank ordered based on the number of disease episodes and rates of hospitalization for a six-year period. We then approached in this order each of the hospital administrators and clinical staff for permission to include their hospital in our study until a total of 24 hospitals consented

Exclusion Criteria:

Refusal by hospital staff to participate in this trial

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00147849

Sponsors and Collaborators

Canadian Institutes of Health Research (CIHR)

Investigators

Principal Investigator:

David W Johnson, MD

University of Calgary

More Information

Study ID Numbers:	MCT-63141, CIHR App No. 110642, U Calgary Acct. No. 73-1051
Study First Received:	September 2, 2005
Last Updated:	November 28, 2005
ClinicalTrials.gov Identifier:	NCT00147849
Health Authority:	Canada: Health Canada

Keywords provided by University of Calgary:

knowledge translation
health care utilization
economic analysis

Study placed in the following topic categories:

Croup
Otorhinolaryngologic Diseases
Respiratory Tract Diseases
Laryngitis
Laryngeal Diseases

ClinicalTrials.gov processed this record on January 16, 2009